#BEGIN_DRUGCARD DB02214

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C11H14N4O8

# Chemical_IUPAC_Name:
8-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,4,5,6,7,8-octahydropteridine-2,4,6,7-tetrone

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
6,7-Dioxo-5h-8-Ribitylaminolumazine

# HET_ID:
RDL

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H14N4O8/c16-2-4(18)6(19)3(17)1-15-7-5(12-9(21)10(15)22)8(20)14-11(23)13-7/h3-4,6,16-19H,1-2H2,(H,12,21)(H2,13,14,20,23)/t3-,4+,6+/m0/s1

# InChI_Key:
InChIKey=MIBROOURCUHKMD-MRKVFDINSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2214

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
330.2509

# Molecular_Weight_Mono:
330.081163444

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1NQU

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2

# Predicted_LogS:
-1.3

# Predicted_Water_Solubility:
1.64e+01 g/l

# Primary_Accession_No:
DB02214

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936323

# PubChem_Substance_ID:
46507403

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02766

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@@H](O)[C@H](O)[C@@H](O)CN1C(=O)C(=O)NC2=C1NC(=O)NC2=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:54 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE000657

# Drug_Target_1_GenBank_ID_Protein:
2982869

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ribH

# Drug_Target_1_Gene_Sequence:
>465 bp
ATGCAAATTTACGAAGGGAAACTAACCGCTGAAGGGCTGAGGTTCGGTATAGTGGCTTCC
AGGTTCAACCACGCACTCGTGGATAGACTAGTTGAGGGAGCTATAGACTGCATAGTAAGA
CACGGGGGAAGGGAAGAAGACATAACGCTCGTTAGAGTGCCGGGCTCCTGGGAAATTCCC
GTGGCTGCGGGAGAGCTTGCGAGAAAAGAGGACATAGACGCTGTGATAGCGATAGGAGTT
CTAATAAGGGGGGCTACTCCCCACTTTGATTACATAGCCTCTGAAGTGTCAAAAGGGCTT
GCGAACCTTTCCTTAGAACTGAGAAAACCCATAACCTTCGGTGTTATAACTGCGGACACC
TTGGAGCAGGCGATAGAAAGGGCGGGAACAAAGCACGGGAATAAGGGCTGGGAAGCTGCA
CTTTCCGCAATAGAAATGGCAAACTTATTTAAGAGTCTGAGATGA

# Drug_Target_1_General_Function:
Coenzyme transport and metabolism

# Drug_Target_1_General_References:
11237620	Zhang X, Meining W, Fischer M, Bacher A, Ladenstein R: X-ray structure analysis and crystallographic refinement of lumazine synthase from the hyperthermophile Aquifex aeolicus at 1.6 A resolution: determinants of thermostability revealed from structural comparisons. J Mol Biol. 2001 Mar 9;306(5):1099-114.
9537320	Deckert G, Warren PV, Gaasterland T, Young WG, Lenox AL, Graham DE, Overbeek R, Snead MA, Keller M, Aujay M, Huber R, Feldman RA, Short JM, Olsen GJ, Swanson RV: The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature. 1998 Mar 26;392(6674):353-8.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2642

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
16705

# Drug_Target_1_Name:
6,7-dimethyl-8-ribityllumazine synthase

# Drug_Target_1_Number_of_Residues:
154

# Drug_Target_1_PDB_ID:
1NQX

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00885	DMRL_synthase

# Drug_Target_1_Protein_Sequence:
>6,7-dimethyl-8-ribityllumazine synthase
MQIYEGKLTAEGLRFGIVASRFNHALVDRLVEGAIDCIVRHGGREEDITLVRVPGSWEIP
VAAGELARKEDIDAVIAIGVLIRGATPHFDYIASEVSKGLANLSLELRKPITFGVITADT
LEQAIERAGTKHGNKGWEAALSAIEMANLFKSLR

# Drug_Target_1_Reaction:
2 6,7-dimethyl-8-(1-D-ribityl)lumazine = riboflavin + 4-(1-D-ribitylamino)-5-amino-2,6-dihydroxypyrimidine

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Riboflavin synthase is a bifunctional enzyme complex catalyzing the formation of riboflavin from 5-amino-6-(1'-D)- ribityl-amino-2,4(1H,3H)-pyrimidinedione and L-3,4-dihydrohy-2- butanone-4-phosphate via 6,7-dimethyl-8-lumazine. The beta subunit catalyzes the condensation of 5-amino-6-(1'-D)-ribityl-amino- 2,4(1H,3H)-pyrimidinedione with L-3,4-dihydrohy-2-butanone-4- phosphate yielding 6,7-dimethyl-8-lumazine

# Drug_Target_1_SwissProt_ID:
O66529

# Drug_Target_1_SwissProt_Name:
RISB_AQUAE

# Drug_Target_1_Synonyms:
DMRL synthase
EC 2.5.1.9
Lumazine synthase
Riboflavin synthase beta chain

# Drug_Target_1_Theoretical_pI:
6.11

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02214
